346 related articles for article (PubMed ID: 29180117)
1. The FOXO3-FOXM1 axis: A key cancer drug target and a modulator of cancer drug resistance.
Yao S; Fan LY; Lam EW
Semin Cancer Biol; 2018 Jun; 50():77-89. PubMed ID: 29180117
[TBL] [Abstract][Full Text] [Related]
2. Integrating bioinformatics and experimental models to investigate the mechanism of the chelidonine-induced mitotic catastrophe via the AKT/FOXO3/FOXM1 axis in breast cancer cells.
Li H; Tang X; Sun Z; Qu Z; Zou X
Biomol Biomed; 2024 May; 24(3):560-574. PubMed ID: 37976368
[TBL] [Abstract][Full Text] [Related]
3. Microbial metabolite restricts 5-fluorouracil-resistant colonic tumor progression by sensitizing drug transporters via regulation of FOXO3-FOXM1 axis.
Ghosh S; Singh R; Vanwinkle ZM; Guo H; Vemula PK; Goel A; Haribabu B; Jala VR
Theranostics; 2022; 12(12):5574-5595. PubMed ID: 35910798
[TBL] [Abstract][Full Text] [Related]
4. Unveiling the potential of FOXO3 in lung cancer: From molecular insights to therapeutic prospects.
Ebrahimnezhad M; Valizadeh A; Majidinia M; Tabnak P; Yousefi B
Biomed Pharmacother; 2024 Jul; 176():116833. PubMed ID: 38843589
[TBL] [Abstract][Full Text] [Related]
5. Favorable outcomes of NPM1
Khan I; Kaempf A; Raghuwanshi S; Chesnokov M; Zhang X; Wang Z; Domling A; Tyner JW; Camacho C; Gartel AL
Blood Cancer J; 2023 Aug; 13(1):128. PubMed ID: 37607920
[No Abstract] [Full Text] [Related]
6. Lactylation regulated DNA damage repair and cancer cell chemosensitivity.
Liu Z; Huang Y; Liu X
Sci Bull (Beijing); 2024 May; 69(9):1185-1187. PubMed ID: 38472020
[No Abstract] [Full Text] [Related]
7. FOXO3 links autophagy to apoptosis.
Fitzwalter BE; Thorburn A
Autophagy; 2018; 14(8):1467-1468. PubMed ID: 29938591
[TBL] [Abstract][Full Text] [Related]
8. Elevated O-GlcNAcylation stabilizes FOXM1 by its reduced degradation through GSK-3β inactivation in a human gastric carcinoma cell line, MKN45 cells.
Inoue Y; Moriwaki K; Ueda Y; Takeuchi T; Higuchi K; Asahi M
Biochem Biophys Res Commun; 2018 Jan; 495(2):1681-1687. PubMed ID: 29196265
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the master regulator FOXM1 in cancer.
Liao GB; Li XZ; Zeng S; Liu C; Yang SM; Yang L; Hu CJ; Bai JY
Cell Commun Signal; 2018 Sep; 16(1):57. PubMed ID: 30208972
[TBL] [Abstract][Full Text] [Related]
10. FOXO3 on the Road to Longevity: Lessons From SNPs and Chromatin Hubs.
Sanese P; Forte G; Disciglio V; Grossi V; Simone C
Comput Struct Biotechnol J; 2019; 17():737-745. PubMed ID: 31303978
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in understanding the role of FOXO3.
Stefanetti RJ; Voisin S; Russell A; Lamon S
F1000Res; 2018; 7():. PubMed ID: 30228872
[TBL] [Abstract][Full Text] [Related]
12. Critical role of FOXO3a in carcinogenesis.
Liu Y; Ao X; Ding W; Ponnusamy M; Wu W; Hao X; Yu W; Wang Y; Li P; Wang J
Mol Cancer; 2018 Jul; 17(1):104. PubMed ID: 30045773
[TBL] [Abstract][Full Text] [Related]
13. FOXM1: a potential therapeutic target in human solid cancers.
Borhani S; Gartel AL
Expert Opin Ther Targets; 2020 Mar; 24(3):205-217. PubMed ID: 32067537
[No Abstract] [Full Text] [Related]
14. FOXM1 modulates 5-FU resistance in colorectal cancer through regulating TYMS expression.
Varghese V; Magnani L; Harada-Shoji N; Mauri F; Szydlo RM; Yao S; Lam EW; Kenny LM
Sci Rep; 2019 Feb; 9(1):1505. PubMed ID: 30728402
[TBL] [Abstract][Full Text] [Related]
15. Molecular regulation and function of FoxO3 in chronic kidney disease.
Lin F
Curr Opin Nephrol Hypertens; 2020 Jul; 29(4):439-445. PubMed ID: 32427691
[TBL] [Abstract][Full Text] [Related]
16. A Convergence-Based Framework for Cancer Drug Resistance.
Konieczkowski DJ; Johannessen CM; Garraway LA
Cancer Cell; 2018 May; 33(5):801-815. PubMed ID: 29763622
[TBL] [Abstract][Full Text] [Related]
17. Reduction of circular RNA Foxo3 promotes prostate cancer progression and chemoresistance to docetaxel.
Shen Z; Zhou L; Zhang C; Xu J
Cancer Lett; 2020 Jan; 468():88-101. PubMed ID: 31593800
[TBL] [Abstract][Full Text] [Related]
18. Pan-Cancer Analyses Reveal Genomic Features of FOXM1 Overexpression in Cancer.
Barger CJ; Branick C; Chee L; Karpf AR
Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30795624
[TBL] [Abstract][Full Text] [Related]
19. RNA m
Lin Z; Niu Y; Wan A; Chen D; Liang H; Chen X; Sun L; Zhan S; Chen L; Cheng C; Zhang X; Bu X; He W; Wan G
EMBO J; 2020 Jun; 39(12):e103181. PubMed ID: 32368828
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
